Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Balchem operates three main business segments—Human Nutrition & Health (~56% of sales), Animal Nutrition & Health (~28%), and Specialty Products (~14%). It leads globally in choline production and microencapsulation technology. The company’s products are widely commercialized across food/beverage/supplement/pharma markets as well as agriculture and industrial sectors. No clinical trial pipeline typical of pharma or biotech companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Balchem Corporation.